DH
Definitive Healthcare Corp.2.2900
-0.0100-0.44%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
238.36MP/E (TTM)
-Basic EPS (TTM)
-1.72Dividend Yield
0%Recent Filings
8-K
Q2 Revenue Down, Guidance Up
Definitive Healthcare reported Q2 2025 revenue of $60.8 million, down 5% from $63.7 million last year, yet net loss narrowed sharply to $9.3 million from $306.2 million after stripping out massive goodwill impairments. Adjusted EBITDA held at $18.7 million, or 31% of revenue, with strong cash flow from operations at $9.3 million. The company raised its full-year revenue guidance to $237–$240 million and adjusted EBITDA to $64–$67 million, signaling confidence in strategic gains. Revenue dipped slightly.
10-Q
Q2 FY2025 results
Definitive Healthcare's Q2 revenue dipped 5% year-over-year to $60.8M, with subscription services down amid sales disruptions and macroeconomic pressures, yet professional services rose 46% to $2.6M. Gross profit held at 77% margin, while operating loss narrowed sharply to $4.2M from $369.6M, thanks to no repeat of last year's massive goodwill impairment. Adjusted EBITDA came in at $18.7M, or 31% margin, edging lower from 33% but signaling cost discipline. Cash and equivalents stood at $81.0M, bolstered by $35.4M in operating cash flow for the half-year, with $49.7M revolver availability and term debt at $169.0M after $73.4M repayments. The Carevoyance asset buy closed in January 2024 for $13.7M cash, adding $7.1M goodwill and intangibles amortized over 6.9 years. Sales execution hiccups linger as a key risk.
8-K
Board resignation and replacement
Definitive Healthcare Corp. announced the resignation of board member Jill Larsen, effective July 21, 2025, due to heightened duties at her employer—no disagreements with company operations noted. The board shrank from 10 to 9 members and promptly named Scott Stephenson as the new Compensation Committee chair. This shift maintains governance continuity amid routine leadership adjustments.
8-K
COO role eliminated
Definitive Healthcare Corp. eliminated the Chief Operating Officer position held by Kate Shamsuddin Jensen on June 25, 2025, as part of executive leadership reorganization. She remains employed until August 1, 2025, with her departure treated as a termination without cause under company agreements. This structural shift streamlines operations. No successor named yet.
8-K
Annual meeting outcomes
Definitive Healthcare Corp. held its 2025 Annual Meeting on June 5, electing Kevin Coop, Jason Krantz, and Lauren Young as Class I directors for three-year terms ending in 2028, with strong support despite some withheld votes. Stockholders ratified Deloitte & Touche LLP as independent auditors for fiscal year 2025 and approved executive compensation on an advisory basis. Votes sailed through, signaling board stability amid routine governance.
IPO
Website
Employees
Sector
Industry
CMHSF
COMPREHENSIVE HEALTHCARE SYS IN
0.35+0.00
DRIO
DarioHealth Corp.
12.05+0.05
FORA
Forian Inc.
2.14+0.00
HCTI
Healthcare Triangle, Inc.
2.09-0.18
HSTM
HealthStream, Inc.
23.91-0.47
PHR
Phreesia, Inc.
16.35-0.35
RMHI
Retrieve Medical Holdings Inc
2.82+0.02
SOPH
SOPHiA GENETICS SA
4.81+0.09
VEEV
Veeva Systems Inc.
219.30-0.80
WORX
SCWorx Corp.
0.21-0.01